Currently, asynchronous visits are not covered by insurance or provincial health plans so you will be charged a visit fee, depending on the category of treatment you are requesting
That is what actually works
Harrison SA, Bashir MR, Guy CD et al (2019) Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Studies of similar medications show 50-70% of lost weight returns within 12-24 months of discontinuation
DM, MAS, TA, YL, WL, and MH conceived and designed the experiments
Advertising Disclosure: This website, along with the products and services mentioned, operates as an advertising marketplace